Johnson & Johnson (NYSE:JNJ) today announced the initiation of a new trial evaluating competitive pulsed field ablation (PFA) technologies. The PERSIGMA RCT pits the company's Varipulse Pro PFA platform against the Boston Scientific Farapulse system. It compares the two leading PFA therapies in treating persistent AFib. Varipulse Pro, which … [Read more...] about Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse
